Published online September 7, 2009
PEDIATRICS Vol. 124 No. 4 October 2009, pp. 1216-1226 (doi:10.1542/peds.2009-1806)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

POLICY STATEMENT

Policy Statement—Recommendations for the Prevention and Treatment of Influenza in Children, 2009–2010

Committee on Infectious Diseases

The purpose of this statement is to update current recommendations for routine use of trivalent seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children.

Key Words: influenza • novel influenza A (H1N1) virus • immunization • live-attenuated influenza vaccine • trivalent inactivated influenza vaccine • vaccine • children • pediatrics

Abbreviations: AAP—American Academy of Pediatrics • TIV—trivalent inactivated influenza vaccine • LAIV—live-attenuated influenza vaccine • FDA—Food and Drug Administration • GBS—Guillain-Barré syndrome • CDC—Centers for Disease Control and Prevention


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?